Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4915 SEK | -2.29% |
|
-1.60% | +7.67% |
07-01 | Active Biotech Enters Agreement for A Clinical Study of Tasquinimod in Myelofibrosis | CI |
05-22 | Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ACTIVE BIOTECH AB | Bio Therapeutic Drugs | -2.29% | -1.60% | +7.67% | -36.17% | -83.62% | 17.13M | ![]() | ![]() | ![]() |
- Stock Market
- Equities
- ACTI Stock
- Charts Active Biotech AB
- Relative Strength Chart